The Global ADC Contract Manufacturing Market is Growing Rapidly Through New Product Development

The global ADC contract manufacturing market involves providing advanced development and manufacturing services for antibody drug conjugates to biopharmaceutical companies. ADC drugs are clinically proven targeted therapies used to treat various forms of cancers. They work by attaching monoclonal antibodies to highly potent anti-cancer payloads or drugs. This allows targeted delivery of cytotoxic agents to cancer cells while reducing unwanted harm to normal cells. Contract manufacturers aid antibodies development by offering state-of-the-art facilities for conjugation, analytics and manufacturing.

The Global ADC Contract Manufacturing Market is estimated to be valued at USD 1.83 Billion in 2024 and is expected to reach USD 4.30 Billion by 2031, growing at a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031.

Key Takeaways

Key players: Key players operating in the global ADC contract manufacturing market include Lonza, Catalent, Siegfried Holding, BioXcellence, and PHC Group. They provide end-to-end development and manufacturing services catering to the distinct needs of biopharmaceutical clients.

Growing demand: The demand for Global ADC Contract Manufacturing Market is growing rapidly due to its high selectivity and efficacy in treating various cancers. Favorable clinical trial results have increased the adoption of ADC therapies. This is driving increased outsourcing of manufacturing and development activities to pure play contract service providers.

Global expansion: Leading contract manufacturers are expanding their ADC capabilities across key markets to address the rising global demand. They are making heavy investments in capacity additions and talent acquisition. Regional expansion allows biopharma companies to access worldwide manufacturing networks and expertise through single partnerships.

Market key trends

One of the key trends in the ADC contract manufacturing market is an increased focus on advanced conjugation technologies. novel linker-payload combinations are being developed to achieve greater drug potency and stability. This requires sophisticated analytical characterization and conjugate analysis capabilities. Contract manufacturers are developing high-yield conjugation processes along with complementary drug development activities to provide end-to-end services. Their technology investments allow for consistent manufacturing of next-gen ADCs with improved pharmacological profiles.
Porter’s Analysis

Threat of new entrants: Low setup costs and technical expertise required to enter this industry poses relatively low threat of new entrants in the global ADC contract manufacturing market.

Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power as buyers in the global ADC contract manufacturing market due to the high competition and flexibility of contract manufacturers.

Bargaining power of suppliers: Suppliers of raw materials for ADC contract manufacturing have moderate bargaining power due to limited availability of specialized components and longstanding customer relationships of reputed manufacturers.

Threat of new substitutes: Threat of substitutes is low as ADC therapeutics are innovative biological drugs with few practical substitutes for the medical conditions they treat.

Competitive rivalry: The global ADC contract manufacturing market experiences high competitive rivalry due to presence of numerous mid-sized players competing for pharma contracts on capability and price.

Geographical regions: North America currently accounts for the largest share in the global ADC contract manufacturing market, mainly driven by substantial R&D investments and approvals of novel ADC drugs in the region.

Asia Pacific is poised to be the fastest growing regional market over the forecast period, attributed to low-cost manufacturing advantages, growing biologics industry and favorable FDI policies adopted by several APAC countries to promote generics and biosimilars production.

Get this Report in Japanese Language: 世界のADC受託製造市場

Get this Report in Korean Language: 글로벌 ADC 계약 제조 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)